3 Boomerang Capital has announced it has closed its flagship private equity fund with more than $375 million.

The fund, 3 Boomerang Capital I, was oversubscribed, exceeding its $350 million target.

3 Boomerang, based in Greenwich, Conn., is focused on lower middle market healthcare companies in North America and Western Europe. Founded in 2023, the firm focuses on biopharma outsourcing, medical device and diagnostic manufacturing, information technology and tech-enabled services, and alternate site care. 3 Boomerang has a flexible investment structure and targets companies with EBITDA of $4 million to $14 million.